Text Size
a
A
About Us
Professionals
Practices
Newsroom
Careers
Contact Us
Menu
Home
About Us
Rankings and Recognition
Diversity and Inclusion
Community Work
Global Network
Professionals
Practices
Newsroom
Press Releases
In the News
Presentations
Publications
Client Alerts
Representative Decisions
Careers
Contact Us
Home
>
Newsroom
>
Client Alerts
>
In re Darvocet: Is There a “Parallel Misbranding” Exception to…
In re Darvocet: Is There a “Parallel Misbranding” Exception to Generic Drug Preemption?
Product Liability
August 1, 2014
Beth S. Rose
> View Alert
< Return to Client Alerts
